EF2_PARKE
ID EF2_PARKE Reviewed; 845 AA.
AC P28996;
DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT 01-DEC-1992, sequence version 1.
DT 03-AUG-2022, entry version 109.
DE RecName: Full=Elongation factor 2;
DE Short=EF-2;
OS Parachlorella kessleri (Green alga) (Chlorella kessleri).
OC Eukaryota; Viridiplantae; Chlorophyta; core chlorophytes; Trebouxiophyceae;
OC Chlorellales; Chlorellaceae; Parachlorella.
OX NCBI_TaxID=3074;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=16668412; DOI=10.1104/pp.97.1.469;
RA Schnelboegl G., Tanner W.;
RT "Amino acid sequence of an algal peptide elongation factor EF-2 deduced
RT from the complementary DNA sequence.";
RL Plant Physiol. 97:469-471(1991).
CC -!- FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step
CC during translation elongation. During this step, the ribosome changes
CC from the pre-translocational (PRE) to the post-translocational (POST)
CC state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound
CC deacylated tRNA move to the P and E sites, respectively. Catalyzes the
CC coordinated movement of the two tRNA molecules, the mRNA and
CC conformational changes in the ribosome.
CC -!- SUBCELLULAR LOCATION: Cytoplasm.
CC -!- PTM: Phosphorylation by EF-2 kinase completely inactivates EF-2.
CC {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC superfamily. Classic translation factor GTPase family. EF-G/EF-2
CC subfamily. {ECO:0000255|PROSITE-ProRule:PRU01059}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M68064; AAA33028.1; -; mRNA.
DR PIR; S32819; S32819.
DR AlphaFoldDB; P28996; -.
DR SMR; P28996; -.
DR PRIDE; P28996; -.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR Gene3D; 3.30.230.10; -; 1.
DR Gene3D; 3.40.50.300; -; 1.
DR InterPro; IPR041095; EFG_II.
DR InterPro; IPR035647; EFG_III/V.
DR InterPro; IPR000640; EFG_V-like.
DR InterPro; IPR004161; EFTu-like_2.
DR InterPro; IPR031157; G_TR_CS.
DR InterPro; IPR027417; P-loop_NTPase.
DR InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR InterPro; IPR014721; Ribosomal_S5_D2-typ_fold_subgr.
DR InterPro; IPR005225; Small_GTP-bd_dom.
DR InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR InterPro; IPR009000; Transl_B-barrel_sf.
DR InterPro; IPR005517; Transl_elong_EFG/EF2_IV.
DR Pfam; PF00679; EFG_C; 1.
DR Pfam; PF14492; EFG_III; 1.
DR Pfam; PF03764; EFG_IV; 1.
DR Pfam; PF00009; GTP_EFTU; 1.
DR Pfam; PF03144; GTP_EFTU_D2; 1.
DR PRINTS; PR00315; ELONGATNFCT.
DR SMART; SM00838; EFG_C; 1.
DR SMART; SM00889; EFG_IV; 1.
DR SUPFAM; SSF50447; SSF50447; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR SUPFAM; SSF54211; SSF54211; 1.
DR SUPFAM; SSF54980; SSF54980; 2.
DR TIGRFAMs; TIGR00231; small_GTP; 1.
DR PROSITE; PS00301; G_TR_1; 1.
DR PROSITE; PS51722; G_TR_2; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; Elongation factor; GTP-binding; Nucleotide-binding;
KW Phosphoprotein; Protein biosynthesis.
FT CHAIN 1..845
FT /note="Elongation factor 2"
FT /id="PRO_0000091009"
FT DOMAIN 17..346
FT /note="tr-type G"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT BINDING 26..33
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 104..108
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT BINDING 158..161
FT /ligand="GTP"
FT /ligand_id="ChEBI:CHEBI:37565"
FT /evidence="ECO:0000250"
FT MOD_RES 57
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250"
FT MOD_RES 59
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250"
FT MOD_RES 702
FT /note="Diphthamide"
FT /evidence="ECO:0000250"
SQ SEQUENCE 845 AA; 94115 MW; 872E4F3925B1AB20 CRC64;
MVKFTIDQIR GLMEYQNNIR NMSVIAHVDH GKSTLTDSLV AAAGIIAFEQ AGDQRLTDTR
ADEQERGITI KSTGISLYYQ MTDEQLKGFT GERQGNDFLI NLIDSPGHVD FSSEVTAALR
ITDGALVVVD CIEGVCVQTE TVLRQALGER IRPVLTINKI DRCFLELMLD PEEAYLAYRR
VIENANVIMA TYADEHLGDT QTHPEAGTVS FSAGLHGWAF TLTVFANMYA AKFGTDTKRM
MEKLWGDNFF DATTRKWTKK HTGADTCKRG FCQFIYEPIK TVIEAAMNDN KDKLFDLLKK
LNVYSKLKPE DRELMGKPLM KRVMQTWLPA HEALLEMMIW HLPSPAKAQK YRVDVLYEGP
LDDTYATAVR NCDADGPLMM YVSKMIPAAD KGRFYAFGRV FSGRIATGRK VRIMGPNYVP
GQKKDLYVKT VQRTVLCMGR RQEAVEDVPC GNTVALVGLD QFITKNATLT DEKCEDAHTI
KAMKFSVSPV VRVAVEPKVA SDLPKLVEGL KRLAKSDPMV QCTIEETGEH IIAGAGELHL
EICLKDLQDD FMGGAEIRVS EPVVSFRETV IGTSDHVVMS KSPNKHNRLY MQARPMEDGL
AEAIDEGKIG PRDDPKVRSK ILSEEFGWDK ELAKKILAFG PDTTGPNMVT DITKGVQYLN
EIKDSVVAAF QWASKEGVLA EENMRGIVFE VCDVVLHADA IHRGGGQIIP TARRSMYAAQ
LTAQPRLLEP VYLVEIQCPE QAMGGVYSVL NQKRGMVFEE LQRPGTPIFN LKAYLPVIES
FGFTSTLRAA TAGQAFPQCV FDHWEAMGSD PTQVGSQANT LVMDIRKRKG LKPEPAALSE
YEDKL